IRhythm Technologies Net Income/Loss 2015-2024 | IRTC
IRhythm Technologies net income/loss from 2015 to 2024. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
| IRhythm Technologies Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2024 | $-113 |
| 2023 | $-123 |
| 2022 | $-116 |
| 2021 | $-101 |
| 2020 | $-44 |
| 2019 | $-55 |
| 2018 | $-50 |
| 2017 | $-30 |
| 2016 | $-21 |
| 2015 | $-23 |
| 2014 | $-16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.538B | $0.493B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.209B | 54.83 |
| Hims & Hers Health (HIMS) | United States | $15.018B | 381.89 |
| Tempus AI (TEM) | United States | $13.495B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.303B | 103.31 |
| Privia Health (PRVA) | United States | $3.060B | 255.00 |
| Enovis (ENOV) | United States | $2.533B | 16.87 |
| Clover Health Investments (CLOV) | United States | $2.280B | 0.00 |
| Azenta (AZTA) | United States | $2.075B | 96.64 |
| Schrodinger (SDGR) | United States | $1.895B | 0.00 |
| Omnicell (OMCL) | United States | $1.858B | 40.53 |
| Phreesia (PHR) | United States | $1.725B | 0.00 |
| 10x Genomics (TXG) | United States | $1.465B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.004B | 0.00 |
| Talkspace (TALK) | United States | $0.652B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.517B | 0.00 |
| TruBridge (TBRG) | United States | $0.426B | 124.04 |
| Nyxoah SA (NYXH) | Belgium | $0.357B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.319B | 0.00 |
| Pulmonx (LUNG) | United States | $0.262B | 0.00 |
| American Well (AMWL) | United States | $0.191B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.088B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.077B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| CareCloud (CCLD) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Outset Medical (OM) | United States | $0.050B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.028B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |